Live Breaking News & Updates on Milestone Event Toward Mainstream

VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing mental health sector.
Health Canada’s announcement could act as a milestone achievement driving advanced research initiatives forward. This includes several ongoing clinical trials that consistently indicate breakthrough therapy potential of psilocybin-assisted psychotherapy for a number of mental health patients suffering from conditions where ....

United States , United Kingdom , British Columbia , Ben Nikolaevsky , Alexander Macgregor , Access Programme , Health Canada Drug Establishment , Empire Communications Group , Toronto Institute Of Pharmaceutical Technology , Transpharm Canada Inc , Pure Extracts Technologies Corp , European Union , Health Canada , Canadian Securities Exchange , Special Access Programme Review Considered , Milestone Event Toward Mainstream , Extracts Technologies , Special Access Programme , Pure Extracts , Dealers Licence , Controlled Drugs , Substances Act , Toronto Institute , Pharmaceutical Technology , North America , Health Canada Drug Establishment License ,